A Single-Arm Study to Evaluate the Effect on Airway Hyperresponsiveness, Safety, Immunogenicity, Pharmacokinetics, and Pharmacodynamics Characteristics of XKH001 Injection in Patients With Allergic Asthma
Latest Information Update: 31 Jul 2025
At a glance
- Drugs XKH 001 (Primary)
- Indications Allergic asthma
- Focus Adverse reactions; Therapeutic Use
- Sponsors Kanova Biopharmaceutical
Most Recent Events
- 31 Jul 2025 New trial record